
Kelvin Supriami
@kelvins_md
Physician-scientist, MMSc (cand.) @harvardmed ‘25. Cardiovascular science, genomics, and prevention 🫀🧬 | @broadinstitute @MGHMedicine
ID: 1632946922662027267
07-03-2023 03:31:20
237 Tweet
168 Followers
555 Following


Two new papers in Nature Genetics from Patrick Ellinor and team Expanding genetic discovery of rare, structural and common variation in atrial fibrillation Sequencing >50K cases nature.com/articles/s4158… GWAS >180K cases nature.com/articles/s4158…


Do you #KnowLpa? High Lp(a) is a common & genetic lipid disorder that increases the risk of heart attack & stroke, yet less than 5% in the US have had it tested. Today Dr Harpreet Bhatia from UC San Diego Cardiology shares the importance of Lp(a) screening. #LpaAwarenessDay #LpaAwarenessMonth.

Dr. Christine E. Seidman, of Harvard Medical School and Brigham and Women's Hospital, will receive the 2025 Paul Dudley White Award! 🏅 Her research has saved lives and advanced precision medicine. She’ll be honored at the Boston Heart and Stroke Ball on April 5. Read more: newsroom.heart.org/local-news/reg…


sjobs.brassring.com/TGnewUI/Search… Come be Sampson Lab for Kidney Genomics Social Media & Community Outreach Coordinator. I am VERY interested in applicants bilingual in Spanish. We're growing by leaps and bounds & there are lots of opportunities to bring your own ideas. Please repost

Defended my master’s thesis few days ago! Couldn’t have reached this point without continuous guidance from my mentor Akl Fahed, colleagues Sarah Urbut Christian Faaborg Andersen MD Michael Honigberg, MD, MPP and many people who have supported me so far. Looking forward to continue doing this!


Incredibly proud of rising star Kelvin Supriami who successfully defended his MMSCI thesis at Harvard Medical School

Presented at #ACC25: Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels. Full ALPACA trial results: nej.md/4kWjJyn American College of Cardiology


New in Circulation #ahajournals, late-breaker at #ACC25 American College of Cardiology E-alerts to providers improved early recognition, referral, AVR rates, and survival for patients with severe & symptomatic AS in a clinical trial Mass General Brigham Sammy Elmariah MD MPH ahajrnls.org/3QVW0k4



Thrilled to share our review on clonal hematopoiesis (and CHIP) in cardiovascular diseases! Michael Honigberg, MD, MPP and I discuss CHIP's potential role as prognostic factor and therapeutic target in atherosclerotic disease, heart failure and arrhythmias nature.com/articles/s4156… Nature Reviews Cardiology


Our latest on 🫀 health, 🧬, & 🤰 now out in JACC Journals #JACC ⬆️ 1st-trimester CV health strongly associates w/ ⬇️ risk of hypertensive disorders of 🤰 (HDP) overall & across levels of HDP 🧬 risk ➡️ opp to prevent 🤰 complications & long-term CVD jacc.org/doi/10.1016/j.…



Join our CTEU Seminar on 4/23 at 9 AM. Dr. Satoshi Koyama from the Broad Institute will give a talk entitled “Advances and Challenges in Cardiovascular Disease Genetics across the Common‑to‑Rare Variant Spectrum.” Chat with us at mghcteu.org to join Zoom.


Hot off the press in Nature Medicine!🎉 Our latest paper sheds light on an often-overlooked question: How much of the global iron deficiency (ID) burden is directly attributable to suboptimal diet? By disentangling dietary causes, we identified the portion of the burden that


Michael Honigberg, M.D., M.P.P., FAHA, MassGeneral News, Harvard Medical School in collaboration with teams from Salem State, Brigham and Women's Hospital & UPMC, is part of a new $15 million initiative to study CKM syndrome in women. spr.ly/60182XJrj 📸: copyright Massachusetts General Hospital



Grateful to have completed my master’s journey in Clinical Investigation at Harvard Medical School. Deep thanks to my PI & mentors who supported me throughout the study Akl Fahed Matt Sampson Krishna Aragam Michael Honigberg, MD, MPP—your guidance & support made this possible. On to the next chapter!


In a large population study from the Korean & Japanese nationwide cohorts, SARS-CoV-2 infection was associated with increased risk of CV outcomes, with risk persisting up to 18 months later but gradually attenuating over time. Min Seo Kim, MD, MSDH ahajournals.org/doi/full/10.11…
